CD8A and neoplasm: In vitro experiments confirmed the function of BHLHE40, with respect to promoting cell migration and invasion via the EMT process, enhancing the stemness of tumor cells, and inhibiting anti-tumor immunity via the promotion of CD8+ T-cell apoptosis.